Geneva Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $1.95M | Buy |
25,691
+673
| +3% | +$51K | 0.03% | 225 |
|
|
2017
Q1 | $1.65M | Buy |
25,018
+1,058
| +4% | +$69.9K | 0.03% | 250 |
|
|
2016
Q4 | $1.52M | Buy |
23,960
+1,359
| +6% | +$86.2K | 0.03% | 257 |
|
|
2016
Q3 | $1.44M | Buy |
22,601
+6,964
| +45% | +$443K | 0.03% | 249 |
|
|
2016
Q2 | $1.16M | Buy |
15,637
+1,345
| +9% | +$100K | 0.02% | 282 |
|
|
2016
Q1 | $955K | Buy |
+14,292
| New | +$955K | 0.02% | 304 |
|